October 2021 – Policy & Medicine

Lex Machina Releases 2021 False Claims Litigation Report

FDA Updates Final Guidance on Biosimilar Development

CMS Proposes to Extend Telehealth Flexibilities Through 2023

Biden Administration Rescinds Trump Administration Insulin Pricing Rule

Senate Introduces Bipartisan Prior Authorization Legislation: Timely Access to Care Act

Higher MIPS Quality Scores Rarely Associated with Lower Complication Rates

CMS Wants to Repeal MCIT Final Rule

Centene to Pay $72 Million to Resolve Allegations by Illinois and Arkansas

CMS Releases Second Interim Final Rule on Surprise Billing

Sutter Health Reaches Largest FCA Settlement Against Hospital System for Alleged MA Fraud